The Bill & Melinda Gates Foundation announced today a commitment of up to $120 million to accelerate access to the investigational antiviral drug molnupiravir for lower-income countries as part of its COVID-19 response effort.
Install Starconnect Media to your Device!
Install
Sign In or Register
Welcome Back!
Login to your account below.
Be the first to get the news as soon as it breaks
Yes!! I'm in
Not Yet
